Company intelligence / Profile preview

Compounding Pharmacy of Manitoba

Oakbank, Manitoba, Canada

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Compounding Pharmacy of Manitoba is the largest compounding facility in Canada, producing custom sterile and non-sterile pharmaceuticals for human and veterinary patients, with services that include oral, topical, injectable, and inhalation products. It was acquired by Grey Wolf Animal Health in December 2024 and continues to operate as a leading provider for tailored medications addressing patient-specific needs, including shortages and discontinued products.

Modalities: Small moleculeBiologicProteinPeptidesHormoneVaccineDevice
Industry: Contract Manufacturing Organization

Partnerships

Pharmacies across CanadaVeterinarians

Beyond the preview

Go deeper on Compounding Pharmacy of Manitoba.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compounding Pharmacy of Manitoba.

Explore the full profile